Corient Private Wealth’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $769K | Buy |
27,865
+5,819
| +26% | +$161K | ﹤0.01% | 1566 |
|
|
2025
Q1 | $625K | Buy |
22,046
+3,508
| +19% | +$99.5K | ﹤0.01% | 1492 |
|
|
2024
Q4 | $771K | Sell |
18,538
-14,459
| -44% | -$601K | ﹤0.01% | 1430 |
|
|
2024
Q3 | $2.21M | Buy |
32,997
+2,604
| +9% | +$174K | ﹤0.01% | 1032 |
|
|
2024
Q2 | $3.61M | Buy |
30,393
+2,561
| +9% | +$304K | 0.01% | 803 |
|
|
2024
Q1 | $2.97M | Buy |
27,832
+4,150
| +18% | +$442K | 0.01% | 853 |
|
|
2023
Q4 | $2.36M | Buy |
23,682
+2,855
| +14% | +$284K | ﹤0.01% | 930 |
|
|
2023
Q3 | $2.15M | Sell |
20,827
-3,597
| -15% | -$372K | 0.01% | 881 |
|
|
2023
Q2 | $2.97M | Sell |
24,424
-9,416
| -28% | -$1.14M | 0.01% | 779 |
|
|
2023
Q1 | $5.2M | Sell |
33,840
-1,185
| -3% | -$182K | 0.01% | 583 |
|
|
2022
Q4 | $6.29M | Buy |
+35,025
| New | +$6.29M | 0.02% | 443 |
|